The researchers selected patients with RVO and macular edema (ME) who met the treatment criteria to conduct individualized treatment for a single case or controlled clinical trials with different durations of 6 months, 9 months, and 12 months have been carried out successively (28–30, 32).A total of 101 patients were enrolled, and the efficacy and safety of TRP combined with anti-VEGF drug injection and drug injection alone were compared. Here, VEGFA is linked to macular retinal edema.